SK40097A3 - A process for the quantitative synthesis of 3-(l-pyroglutamyl)-l- -thiazolidine-4-carboxylic acid and derivatives thereof - Google Patents
A process for the quantitative synthesis of 3-(l-pyroglutamyl)-l- -thiazolidine-4-carboxylic acid and derivatives thereof Download PDFInfo
- Publication number
- SK40097A3 SK40097A3 SK400-97A SK40097A SK40097A3 SK 40097 A3 SK40097 A3 SK 40097A3 SK 40097 A SK40097 A SK 40097A SK 40097 A3 SK40097 A3 SK 40097A3
- Authority
- SK
- Slovakia
- Prior art keywords
- halide
- compound
- formula
- thiazolidine
- carboxylic acid
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 22
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 claims abstract description 8
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 claims abstract description 7
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims abstract description 5
- 230000007062 hydrolysis Effects 0.000 claims abstract description 4
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 4
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 3
- 239000003444 phase transfer catalyst Substances 0.000 claims abstract description 3
- -1 ligroin Chemical compound 0.000 claims description 26
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 18
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 8
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 6
- 239000000010 aprotic solvent Substances 0.000 claims description 6
- 125000004494 ethyl ester group Chemical group 0.000 claims description 5
- 150000004820 halides Chemical class 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims description 4
- RWGFKTVRMDUZSP-UHFFFAOYSA-N cumene Chemical compound CC(C)C1=CC=CC=C1 RWGFKTVRMDUZSP-UHFFFAOYSA-N 0.000 claims description 4
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 claims description 4
- BKIMMITUMNQMOS-UHFFFAOYSA-N nonane Chemical compound CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 claims description 4
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims description 2
- BDNKZNFMNDZQMI-UHFFFAOYSA-N 1,3-diisopropylcarbodiimide Chemical compound CC(C)N=C=NC(C)C BDNKZNFMNDZQMI-UHFFFAOYSA-N 0.000 claims description 2
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 claims description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 2
- 230000003213 activating effect Effects 0.000 claims description 2
- 125000005099 aryl alkyl carbonyl group Chemical group 0.000 claims description 2
- 125000005129 aryl carbonyl group Chemical group 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- BGRWYRAHAFMIBJ-UHFFFAOYSA-N diisopropylcarbodiimide Natural products CC(C)NC(=O)NC(C)C BGRWYRAHAFMIBJ-UHFFFAOYSA-N 0.000 claims description 2
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 claims description 2
- XKBGEWXEAPTVCK-UHFFFAOYSA-M methyltrioctylammonium chloride Chemical compound [Cl-].CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC XKBGEWXEAPTVCK-UHFFFAOYSA-M 0.000 claims description 2
- 239000003208 petroleum Substances 0.000 claims description 2
- 125000003107 substituted aryl group Chemical group 0.000 claims description 2
- 239000008096 xylene Substances 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- MJLQPFJGZTYCMH-LURJTMIESA-N (2s)-1-[(2-methylpropan-2-yl)oxycarbonyl]-5-oxopyrrolidine-2-carboxylic acid Chemical compound CC(C)(C)OC(=O)N1[C@H](C(O)=O)CCC1=O MJLQPFJGZTYCMH-LURJTMIESA-N 0.000 claims 1
- 229960004830 cetylpyridinium Drugs 0.000 claims 1
- MZMRZONIDDFOGF-UHFFFAOYSA-M hexadecyl(trimethyl)azanium;4-methylbenzenesulfonate Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1.CCCCCCCCCCCCCCCC[N+](C)(C)C MZMRZONIDDFOGF-UHFFFAOYSA-M 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- DZLNHFMRPBPULJ-UHFFFAOYSA-N thioproline Chemical class OC(=O)C1CSCN1 DZLNHFMRPBPULJ-UHFFFAOYSA-N 0.000 abstract description 3
- 230000005494 condensation Effects 0.000 abstract 2
- 238000009833 condensation Methods 0.000 abstract 2
- 239000002904 solvent Substances 0.000 abstract 2
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 abstract 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 150000002148 esters Chemical class 0.000 description 6
- DZLNHFMRPBPULJ-GSVOUGTGSA-N D-thioproline Chemical compound OC(=O)[C@H]1CSCN1 DZLNHFMRPBPULJ-GSVOUGTGSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- SHFJWMWCIHQNCP-UHFFFAOYSA-M hydron;tetrabutylazanium;sulfate Chemical compound OS([O-])(=O)=O.CCCC[N+](CCCC)(CCCC)CCCC SHFJWMWCIHQNCP-UHFFFAOYSA-M 0.000 description 3
- IZUPBVBPLAPZRR-UHFFFAOYSA-N pentachlorophenol Chemical compound OC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl IZUPBVBPLAPZRR-UHFFFAOYSA-N 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- RMHPSSGICDJKDR-VKHMYHEASA-N (2s)-5-oxopyrrolidine-2-carbonyl chloride Chemical compound ClC(=O)[C@@H]1CCC(=O)N1 RMHPSSGICDJKDR-VKHMYHEASA-N 0.000 description 2
- ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 description 2
- CFMZSMGAMPBRBE-UHFFFAOYSA-N 2-hydroxyisoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(O)C(=O)C2=C1 CFMZSMGAMPBRBE-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- ZRBNETYZYOXTLS-UHFFFAOYSA-N ethyl 1,3-thiazolidine-4-carboxylate Chemical compound CCOC(=O)C1CSCN1 ZRBNETYZYOXTLS-UHFFFAOYSA-N 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- RZTLLWYMTFATOM-UHFFFAOYSA-N 2,2-dimethylpropanoylazanium;4-methylbenzenesulfonate Chemical compound CC(C)(C)C([NH3+])=O.CC1=CC=C(S([O-])(=O)=O)C=C1 RZTLLWYMTFATOM-UHFFFAOYSA-N 0.000 description 1
- XBNGYFFABRKICK-UHFFFAOYSA-N 2,3,4,5,6-pentafluorophenol Chemical compound OC1=C(F)C(F)=C(F)C(F)=C1F XBNGYFFABRKICK-UHFFFAOYSA-N 0.000 description 1
- LHJGJYXLEPZJPM-UHFFFAOYSA-N 2,4,5-trichlorophenol Chemical compound OC1=CC(Cl)=C(Cl)C=C1Cl LHJGJYXLEPZJPM-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- ZRBNETYZYOXTLS-YFKPBYRVSA-N ethyl (4r)-1,3-thiazolidine-4-carboxylate Chemical compound CCOC(=O)[C@@H]1CSCN1 ZRBNETYZYOXTLS-YFKPBYRVSA-N 0.000 description 1
- SQRLNYSSTHJCIU-JEDNCBNOSA-N ethyl (4r)-1,3-thiazolidine-4-carboxylate;hydrochloride Chemical compound Cl.CCOC(=O)[C@@H]1CSCN1 SQRLNYSSTHJCIU-JEDNCBNOSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- GBXQPDCOMJJCMJ-UHFFFAOYSA-M trimethyl-[6-(trimethylazaniumyl)hexyl]azanium;bromide Chemical compound [Br-].C[N+](C)(C)CCCCCC[N+](C)(C)C GBXQPDCOMJJCMJ-UHFFFAOYSA-M 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06173—Dipeptides with the first amino acid being heterocyclic and Glp-amino acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
- Pyrrole Compounds (AREA)
Abstract
Description
Spôsob výroby kyseliny 3-(L-pyroglutamyl)-L-tiazolidín-4karboxylovej a jej derivátovProcess for the preparation of 3- (L-pyroglutamyl) -L-thiazolidine-4-carboxylic acid and its derivatives
Oblasť technikyTechnical field
Predkladaný vynález sa týka postupu prípravy kyseliny L-pyroglutámovej alebo jej derivátov.The present invention relates to a process for the preparation of L-pyroglutamic acid or derivatives thereof.
Doterajší stav technikyBACKGROUND OF THE INVENTION
Taliansky patent č. 1 202 426 opisuje kyselinu 3-(L-pyroglutamyl)-L-tiazolidín-4-karboxylovú, ktorá má imunostimulačné, antitoxické, protizápalové, antioxidačné vlastnosti a vlastnosti spomaľovania stárnutia a pripravuje sa z reaktívneho esteru kyseliny L-pyroglutámovej alebo z jej chloridu a z kyseliny L-tiazolidín-4-karboxylpvej.Italian patent no. No. 1,202,426 discloses 3- (L-pyroglutamyl) -L-thiazolidine-4-carboxylic acid having immunostimulatory, antitoxic, anti-inflammatory, antioxidant and aging retarding properties and is prepared from a reactive ester of L-pyroglutamic acid or its chloride and from L-thiazolidine-4-carboxylic acid.
V postupe sú použité najmä napríklad reaktívne estery kyseliny L-glutámovej s pentachlorfenolom, pentafluorfenolom, 2,4,5-trichlorfenolom, N-hydr.oxysukcínimidom, N-hydroxyftalimidom, ktoré reagujú s kyselinou L-tiazolidín-4-karboxylovou v aprotických rozpúšťadlách za prítomnosti terciárnych báz, alebo chloridu kyseliny L-pyroglutámovej, ktorý reaguje s kyselinou L-tiazolidín-4-karboxylovou v alkalickom médiu.In particular, the reactive esters of L-glutamic acid with pentachlorophenol, pentafluorophenol, 2,4,5-trichlorophenol, N-hydrosuccinimide, N-hydroxyphthalimide, which react with L-thiazolidine-4-carboxylic acid in aprotic solvents, are used in the process. the presence of tertiary bases, or L-pyroglutamic acid chloride, which reacts with L-thiazolidine-4-carboxylic acid in an alkaline medium.
Taliansky patent č. 1 230 706 opisoval deriváty kyseliny 3-(L-pyroglutamyl)-L-tiazolidín-4-karboxylovej, ktoré majú rovnaké farmakologické účinky a ktoré sa pripravujú podobnými postupmi z reaktívnych esterov alebo amidov kyseliny L-pyroglutamyl-tiazolidín-4-karboxylovej a alkoholov alebo amínov.Italian patent no. No. 1,230,706 described 3- (L-pyroglutamyl) -L-thiazolidine-4-carboxylic acid derivatives having the same pharmacological effects and prepared by similar procedures from L-pyroglutamyl-thiazolidine-4-carboxylic acid reactive esters or amides and alcohols or amines.
Z praktického hľadiska majú tieto postupy niektoré nedostatky, menovite: obtiažne postupy s extrémne nízkymi celkovými výťažkami, použitie látok vysoko toxických pre človeka a životné prostredie, ako sú napríklad halogenované fenoly, použitie L-pyroglutamylchloridu, ktorý sa ťažko pripravuje a s ktorým sa ťažko pracuje, ako aj slabá stabilita reaktívnych esterov kyseliny L-pyroglutamovej s N-hydroxysuk2 cínimidom a N-hydroxyftalimidom.In practice, these processes have some drawbacks, namely: difficult processes with extremely low overall yields, the use of highly toxic to humans and the environment, such as halogenated phenols, the use of L-pyroglutamyl chloride, which is difficult to prepare and difficult to handle, as well as poor stability of the reactive esters of L-pyroglutamic acid with N-hydroxysuccinimide and N-hydroxyphthalimide.
Taliansky patent č. 1 239 029 opisuje postup, kde sa vyššie spomenuté problémy čiastočne vyriešili pomocou jednoduchšieho postupu, bez použitia zvlášť toxických látok, náročných a/alebo nestabilných medziproduktov a s vyššími výťažkami. Takýto postup sa prejavil prekvapujúcou stabilitou etyltiazolidín-4-karboxylátu za získania podstatne vyšších výťažkov ako v prípade použitia iných jednoduchých esterov, ako napríklad metyl- a izopropylesterov.Italian patent no. No. 1,239,029 discloses a process wherein the above-mentioned problems have been partially solved by a simpler process, without the use of particularly toxic substances, demanding and / or unstable intermediates, and with higher yields. Such a process has shown the surprising stability of ethylthiazolidine-4-carboxylate to yield substantially higher yields than other simple esters such as methyl and isopropyl esters.
Teraz sa zistilo, že uvedený postup možno ďalej zdokonaľovať, aby sa získali takmer kvantitatívne výťažky požadovaných produktov, pomocou kondenzácie etyltiazolidín-4-karboxylátu alebo jeho derivátu s derivátom kyseliny L-pyroglutámovej v apolárnych aprotických rozpúšťadlách a konečne hydrolýzou etylesteru v podmienkach fázového prenosu.It has now been found that the process can be further improved to obtain almost quantitative yields of the desired products, by condensing ethylthiazolidine-4-carboxylate or a derivative thereof with an L-pyroglutamic acid derivative in apolar aprotic solvents and finally hydrolyzing the ethyl ester under phase transfer conditions.
Podstata vynálezuSUMMARY OF THE INVENTION
Preto vynález poskytuje spôsob prípravy zlúčeniny vzorca III,Therefore, the invention provides a process for the preparation of a compound of formula III,
kde R·*· je H, C^-Cgalkyl, -Cycykloalkyl, C^-C^Qcykloalkylalkyl, aryl a substituovaný aryl, C2-C5alkoxykarbonyl, C2“CiQalkylkarbonyl, arylkarbonyl a aralkylkarbonyl, Cg-C^garalkoxykarbonyl, substituovaný aralkoxykarbonyl, ktorý zahrnuj e:wherein R 6 is H, C 1 -C 6 alkyl, -Cycycloalkyl, C 1 -C 6 cycloalkylalkyl, aryl and substituted aryl, C 2 -C 5 alkoxycarbonyl, C 2 -C 6 alkylcarbonyl, arylcarbonyl and aralkylcarbonyl, C 6 -C 6 garalkoxycarbonyl, substituted aralkoxycarbonyl, includes:
a) reakciu zlúčeniny vzorca I ,a) reaction of a compound of formula I,
(I) kde R1 je, ako už bolo definované a X je OH, Cl alebo OR2, kde R2 je aktivujúca skupina, so zlúčeninou vzorca II,(I) wherein R 1 is as defined above and X is OH, Cl or OR 2 , wherein R 2 is an activating group, with a compound of formula II,
kde je H, C3-Cgtrialkylsilyl, v apolárnych aprotických rozpúšťadlách;wherein H is C 3 -C 8trialkylsilyl, in apolar aprotic solvents;
b) zásaditú hydrolýzu etylesteru získaného v kroku a) za podmienok fázového prenosu.b) basic hydrolysis of the ethyl ester obtained in step a) under phase transfer conditions.
Apolárne aprotické rozpúšťadlá sú vybrané najmä z n-pentánu, n-hexánu, n-heptánu, n-oktánu, izooktánu, nonánu, dekánu, petroléteru, ligroínu, toluénu, xylénu, kuménu, dichlormetánu, chloroformu, dichloretánu a ich zmesí. Ak sa použije zlúčenina vzorca I, kde X = OH, reakcia so zlúčeninou vzorca II sa uskutočňuje v prítomnosti kondenzačného činidla, ako napríklad dicyklohexylkarbodiimidu alebo diizopropylkarbodiimidu.The apolar aprotic solvents are particularly selected from n-pentane, n-hexane, n-heptane, n-octane, isooctane, nonane, decane, petroleum ether, ligroin, toluene, xylene, cumene, dichloromethane, chloroform, dichloroethane and mixtures thereof. When a compound of formula I wherein X = OH is used, the reaction with the compound of formula II is carried out in the presence of a condensing agent such as dicyclohexylcarbodiimide or diisopropylcarbodiimide.
Etylester získaný v kroku a) je transformovaný do zodpovedajúcej kyseliny, v kvantitatívnom výťažku, v podmienkach miernej hydrolýzy pomocou katalyzátorov fázového prenosu v zásaditom médiu.The ethyl ester obtained in step a) is transformed into the corresponding acid, in quantitative yield, under conditions of moderate hydrolysis by phase transfer catalysts in a basic medium.
V tomto kroku sa používajú katalyzátory ako tetrabutylamóniumhalogenid alebo hydrogénsíran alebo tetrafluórborát, tetraetylamóniumhalogenid alebo hydrogénsíran alebo tetrafluorborát; cetypyrdíniumhalogenid, metyltributyhalogenid, Adogen 464, trimetycetylamónium-p-toluéňsulfonát, tetrabutylfosfóniumhalogenid, tetrafenylfosfóniumhalogenid, trifenylmetylfosfóniumhalogenid, butylpyridíniumhalogenid.Catalysts such as tetrabutylammonium halide or hydrogen sulphate or tetrafluoroborate, tetraethylammonium halide or hydrogen sulphate or tetrafluoroborate are used in this step; cetypyridinium halide, methyltributyl halide, Adogen 464, trimethylacetyl ammonium p-toluenesulfonate, tetrabutylphosphonium halide, tetrafenylphosphonium halide, triphenylmethylphosphonium halide, butylpyridinium halide.
Za týchto podmienok, za použitia derivátov kyseliny tiazolidín-4-karboxylovej esterifikovaných metanolom, propanolom alebo izopropanolom sa získajú výrazne nižšie výťažky. Nasledovné príklady sú použité na ilustráciu predkladaného vynálezu.Under these conditions, significantly lower yields are obtained using thiazolidine-4-carboxylic acid derivatives esterified with methanol, propanol or isopropanol. The following examples are used to illustrate the present invention.
Príklady uskutočnenia vynálezuDETAILED DESCRIPTION OF THE INVENTION
Príklad 1Example 1
16,78 g etyl L-tiazolidín-4-karboxylát hydrochloridu (0,084 molu) sa suspeiiduje v 160 ml toluénu, pridá sa 7,06 g hydrogénuhličitanu sodného (0,085 molov), zohrieva sa do refluxu za miešania 5 hodín, azeotrópne sa odstráni voda. Zmes sa ochladí na 0 až 5 ‘C, pridá sa 12 g kyseliny L-pyroglutámovej (0,093 molov), potom sa po kvapkách pridá roztok 19,2 g dicyklohexylkarbodiimidu v 20 ml toluénu. Po 1 hodine pri 0 °C sa teplota zvýši na 20 až 25 °C na ďalších 12 hodín, potom sa odfiltruje dicyklohexylmočovina.16.78 g of ethyl L-thiazolidine-4-carboxylate hydrochloride (0.084 mol) are suspended in 160 ml of toluene, 7.06 g of sodium bicarbonate (0.085 mol) are added, heated to reflux with stirring for 5 hours, water is azeotropically removed . The mixture is cooled to 0-5 ° C, 12 g of L-pyroglutamic acid (0.093 moles) are added, then a solution of 19.2 g of dicyclohexylcarbodiimide in 20 ml of toluene is added dropwise. After 1 hour at 0 ° C the temperature is raised to 20-25 ° C for an additional 12 hours, then the dicyclohexylurea is filtered off.
Prefiltrovaný roztok sa doplní 20 ml vody, pridá sa 0,64 g tetrabutylamóniumhydrogénsulfátu (0,0042 molov), ochladí sa na 0 až 5 °C, potom sa pridá roztok 3,36 g hydroxidu sodného (0,084 molov) v 20 ml vody. Po miešaní 30 minút sa odseparuje vodná fáza, okyslí sa na pH 1 kyselinou chlorovodíkovou, po 2 hodinách sa roztok prefiltruje, premyje sa vodou a vysuší sa, aby sa získalo 19,5 g (96 %) kyselinyThe filtered solution is made up to 20 ml with water, 0.64 g of tetrabutylammonium hydrogen sulphate (0.0042 moles) is added, cooled to 0-5 ° C, then a solution of 3.36 g of sodium hydroxide (0.084 moles) in 20 ml of water is added. After stirring for 30 minutes, the aqueous phase is separated, acidified to pH 1 with hydrochloric acid, after 2 hours the solution is filtered, washed with water and dried to give 19.5 g (96%) of the acid.
3-(L-pyroglutamyl)-L-tiazolidín-4-karboxylovej, t.t. 193 až 194 ’C.3- (L-pyroglutamyl) -L-thiazolidine-4-carboxylic acid, m.p. 193 to 194 ’C.
Príklad 2Example 2
Postup prebieha ako v príklade 1, toluén je nahradený dichlormetánom, aby sa získalo 19,2 g (95 %) kyseliny 3-(Lpyroglutamyl)-L-tiazolidín-4-karboxylovej, t.t. 193 až 194 ’C.Operating as in Example 1, toluene is replaced with dichloromethane to give 19.2 g (95%) of 3- (Lpyroglutamyl) -L-thiazolidine-4-carboxylic acid, m.p. 193 to 194 ’C.
Príklad 3Example 3
Postup prebieha ako v príklade 1, toluén je nahradený N-hexánom, aby sa získalo 19,1 g (94 %) kyseliny 3-(L-pyroglutamyl) -L-tiazolidín-4-karboxylovej , t.t. 193 až 194 ’C.Operating as in Example 1, toluene is replaced with N-hexane to give 19.1 g (94%) of 3- (L-pyroglutamyl) -L-thiazolidine-4-carboxylic acid, m.p. 193 to 194 ’C.
Príklad 4 g kyseliny L-N-t-butoxykarbonylpyroglutámovej a 16,1 g etyl-L-tiazolidín-4-karboxylátu sa rozpustí v 150 ml dichlórmetánu, ochladí sa na 0,5 °C, potom sa pridá 21 g dicyklohexylkarbodiimidu (0,105 molov) a mieša sa 15 hodín pri uvedenej teplote.Example 4 g of LNt-butoxycarbonylpyroglutamic acid and 16.1 g of ethyl L-thiazolidine-4-carboxylate are dissolved in 150 ml of dichloromethane, cooled to 0.5 ° C, then 21 g of dicyclohexylcarbodiimide (0.105 moles) are added and stirred 15 hours at the indicated temperature.
Dicyklohexylmočovina sa odfiltruje, potom sa filtrát doplní 50 ml vody, 0,75 g tetrabutylamóniumhydrogénsulfátu (0,005 molov). Zmes sa ochladí na 0 až 5 °C, potom sa roztok 6,6 g hydroxydu draselného (0,1 molu) v 30 ml vody pridá k zmesi, mieša sa pri tejto teplote 30 minút, potom sa obe fázy odseparujú. Vodná fáza sa okyslí na pH 1 koncentrovanou kyselinou chlorovodíkovou. Precipitovaná tuhá látka sa odfiltruje, premyje vodou a vysuší. Získa sa 21,3 g kyseliny 3-(L-pyroglutamyl)-L-tiazolidín-4-karboxylovej, t.t. 193 až 194 “C, výťažok 88 %.The dicyclohexylurea is filtered off, then the filtrate is made up with 50 ml of water, 0.75 g of tetrabutylammonium hydrogen sulfate (0.005 mol). The mixture is cooled to 0-5 ° C, then a solution of 6.6 g of potassium hydroxide (0.1 mol) in 30 ml of water is added to the mixture, stirred at this temperature for 30 minutes, then the two phases are separated. The aqueous phase is acidified to pH 1 with concentrated hydrochloric acid. The precipitated solid is filtered off, washed with water and dried. 21.3 g of 3- (L-pyroglutamyl) -L-thiazolidine-4-carboxylic acid are obtained, m.p. 193-194 ° C, yield 88%.
Nasledovná tabuľka vyjadruje výsledky získané za použitia esterov kyseliny L-tiazolidín-4-karboxylovej; v prípade tejto patentovej žiadosti ide o etylester, ktorý reagoval za tých istých podmienok, ako bolo uvedené vo vyššie spomenutých príkladoch.The following table shows the results obtained using L-thiazolidine-4-carboxylic acid esters; this patent application is an ethyl ester which reacted under the same conditions as those described in the above examples.
Tabuľkatable
Claims (9)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI941955A IT1270017B (en) | 1994-09-27 | 1994-09-27 | "QUANTITATIVE SYNTHESIS OF 3- (L-PIROGLUTAMIL) -L-THIAZOLIDIN-4- CARBOXYLIC ACID AND ITS DERIVATIVES" |
| PCT/EP1995/003720 WO1996010036A1 (en) | 1994-09-27 | 1995-09-21 | A process for the quantitative synthesis of 3-(l-pyroglutamyl)-l-thiazolidine-4-carboxylic acid and derivatives thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK40097A3 true SK40097A3 (en) | 1997-09-10 |
Family
ID=11369599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK400-97A SK40097A3 (en) | 1994-09-27 | 1995-09-21 | A process for the quantitative synthesis of 3-(l-pyroglutamyl)-l- -thiazolidine-4-carboxylic acid and derivatives thereof |
Country Status (10)
| Country | Link |
|---|---|
| CN (1) | CN1143863C (en) |
| BG (1) | BG63895B1 (en) |
| BR (1) | BR9509087A (en) |
| CO (1) | CO4480030A1 (en) |
| CZ (1) | CZ91597A3 (en) |
| IT (1) | IT1270017B (en) |
| PL (1) | PL181824B1 (en) |
| RO (1) | RO115957B1 (en) |
| SK (1) | SK40097A3 (en) |
| WO (1) | WO1996010036A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108088936B (en) * | 2017-12-08 | 2020-05-22 | 常州寅盛药业有限公司 | Impurity obtained in preparation of pidotimod ethyl ester and quality detection method thereof |
| CN108715598A (en) * | 2018-06-13 | 2018-10-30 | 峨眉山宏昇药业股份有限公司 | A kind of preparation method of Pidotimod |
| CN117088939A (en) * | 2022-05-11 | 2023-11-21 | 江苏吴中医药集团有限公司 | A kind of preparation method of Pidotimod |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1202426B (en) * | 1987-01-26 | 1989-02-09 | Poli Ind Chimica Spa | THIAZOLIDIN-4-CARBOXYLIC ACID DERIVATIVE, ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT |
| IT1239029B (en) * | 1989-10-12 | 1993-09-20 | Poli Ind Chimica Spa | PROCESS FOR THE PREPARATION OF 3- (L-PYROGLUTAMYL) -L- THIAZOLIDIN-4-CARBOXYLIC ACID AND ITS DERIVATIVES. |
-
1994
- 1994-09-27 IT ITMI941955A patent/IT1270017B/en active IP Right Grant
-
1995
- 1995-09-21 PL PL95319380A patent/PL181824B1/en unknown
- 1995-09-21 WO PCT/EP1995/003720 patent/WO1996010036A1/en not_active Ceased
- 1995-09-21 BR BR9509087A patent/BR9509087A/en not_active Application Discontinuation
- 1995-09-21 CZ CZ97915A patent/CZ91597A3/en unknown
- 1995-09-21 SK SK400-97A patent/SK40097A3/en unknown
- 1995-09-21 CN CNB951953222A patent/CN1143863C/en not_active Expired - Lifetime
- 1995-09-21 RO RO97-00611A patent/RO115957B1/en unknown
- 1995-09-27 CO CO95044814A patent/CO4480030A1/en unknown
-
1997
- 1997-03-11 BG BG101310A patent/BG63895B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL181824B1 (en) | 2001-09-28 |
| WO1996010036A1 (en) | 1996-04-04 |
| BR9509087A (en) | 1998-07-21 |
| CN1143863C (en) | 2004-03-31 |
| BG101310A (en) | 1997-12-30 |
| CZ91597A3 (en) | 1997-09-17 |
| ITMI941955A0 (en) | 1994-09-27 |
| PL319380A1 (en) | 1997-08-04 |
| RO115957B1 (en) | 2000-08-30 |
| IT1270017B (en) | 1997-04-16 |
| BG63895B1 (en) | 2003-05-30 |
| CO4480030A1 (en) | 1997-07-09 |
| CN1158620A (en) | 1997-09-03 |
| ITMI941955A1 (en) | 1996-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI72719C (en) | SYNTESFOERFARANDE FOER PIROXIKAM SAMT MELLANPRODUKT. | |
| FI95271C (en) | Process for preparing 3- (L-pyroglutamyl) -L-thiazolidine-4-carboxylic acid and its N-substituted derivatives | |
| NZ234934A (en) | Dihydrobenzofuran derivatives; medicaments | |
| US5545654A (en) | Pleuromutilin derivatives | |
| EP0080229B1 (en) | Salicylic derivatives of n-acetylcysteine | |
| SK40097A3 (en) | A process for the quantitative synthesis of 3-(l-pyroglutamyl)-l- -thiazolidine-4-carboxylic acid and derivatives thereof | |
| US4125625A (en) | Troponyl-oxamic acid derivatives | |
| JPH03291267A (en) | Preparation of substituted notroguanidines | |
| ZA200502694B (en) | Aplha-phenyl acetanilide derivatives having an acat inhibiting activity and therapeutic application thereof. | |
| US4152456A (en) | Tropone derivatives | |
| US4886908A (en) | Method of preparing (R)-4-amino-3-hydroxybutyric acid | |
| Rosen et al. | The Synthesis of Spin Labeled Acetylcholine Analogs | |
| US4183955A (en) | Troponyl-oxamic acid derivatives for treating allergic conditions | |
| JP2000503666A (en) | Camptothecin isolated from Mappia foetida-backbone compounds and their use as synthons for novel pharmaceutical and therapeutic agents | |
| JPH05221941A (en) | Carboxylic acid ester protecting group, formation thereof,coupling to functional group thereof and use thereof | |
| MC1195A1 (en) | ACYLUS DERIVATIVES | |
| CN1035005C (en) | A new method for preparing 6-(3-dimethylaminopropionyl)forskolin | |
| Lal et al. | In search of novel water soluble forskolin analogues for positive inotropic activity | |
| FI79298B (en) | NOW FOERFARANDE FOER FRAMSTAELLNING AV GLUTAMYLTAURIN. | |
| WO1993018059A2 (en) | L-thiazolidine-4-carboxylic acid derivative, processes for the preparation thereof and the use thereof in therapy | |
| SU527134A3 (en) | Method for preparing benzylamine derivatives or their salts | |
| KR950009316B1 (en) | Process for preparing pyrrolidinecarboxylic acid derivative | |
| PT97320B (en) | PROCESS FOR THE PREPARATION OF ACID DERIVATIVES 6-FLUOR-1,4-DIHYDRO-4-OXO-7-PIPERAZINYL-KINOLINOCARBOXYL ACID | |
| MC1104A1 (en) | NEW N-ALKANOL SUBSTITUTED HETEROCYCLIC AMINES, THEIR DERIVATIVES, THEIR METHODS OF PREPARATION |